Cleared Dual Track

K171976 - Sofia Strep A+ FIA, Sofia 2 Analyzer

K171976 is an FDA 510(k) clearance for Sofia Strep A+ FIA, manufactured by Quidel Corporation. The device is a Class 1 Microbiology device with product code GTY cleared through the Dual Track 510(k) pathway after a 174-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2017
Decision
174d
Days
Class 1
Risk

K171976 is an FDA 510(k) clearance for the Sofia Strep A+ FIA, Sofia 2 Analyzer. Classified as Antigens, All Groups, Streptococcus Spp. (product code GTY), Class I - General Controls.

Submitted by Quidel Corporation (San Diego,, US). The FDA issued a Cleared decision on December 21, 2017 after a review of 174 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Quidel Corporation devices

FDA 510(k) Submission Details - K171976

510(k) Number K171976 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2017
Decision Date December 21, 2017
Days to Decision 174 days
Submission Type Dual Track
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 102d · This submission: 174d
Pathway characteristics

GTY Device Classification - Class 1, General Controls

Product Code GTY Antigens, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTY Antigens, All Groups, Streptococcus Spp.

All 37
Devices cleared under the same product code (GTY) and FDA review panel - the closest regulatory comparables to K171976.
AllTest Strep A Rapid Test
K260342 · Hangzhou AllTest Biotech Co., Ltd. · Apr 2026
Flowflex® Plus Strep A Rapid Test Cassette
K251697 · ACON Laboratories, Inc. · Nov 2025
Healgen Strep A Rapid Test Strip (Throat Swab)
K212623 · Healgen Scientific, LLC · Mar 2022
SOFIA (R) STREP A+ FIA
K141775 · Quidel Corporation · Dec 2014
WONDFO RAPID STREP A TEST
K133343 · Guangzhou Wondfo Biotech Co., Ltd. · Jan 2014
SOFIA STREP A FIA
K123793 · Quidel Corporation · Jun 2013